by Caroline Adenberger

with expert contributions on
Stem Cell Research in the UK: the Cutting Edge of Science and Regulation by Joshua Mandell
Switzerland: The Stem Cell Research Act by Dora Fitzli

From California to Singapore, scientists around the globe race to be the first to unveil the hidden promises of stem cell research, with special hope for the potential of embryonic stem (ES) cells. But besides the expected trials and errors in research, scientists also have to face barriers outside their labs: Uncertain policies and different legal frameworks make progress in ES cell research even more complicated. After reporting on the legal situation in the US in the last edition of bridges, the present article focuses on the funding situation in the European Union (EU). The article is supplemented with expert contributions on the state of embryonic stem cell research in Switzerland (see also bridges article in this issue 'Switzerland: The Stem Cell Research Act') by the Swiss Science Attaché to the United States Dora Fitzli, and on the situation in the United Kingdom (see also bridges article in this issue 'Stem Cell Research in the UK: the Cutting Edge of Science and Regulation') by Joshua Mandell, the Senior Science & Technology Adviser of the Royal British Embassy in Washington, DC

Access to the full article is free, but requires you to register. Registration is simple and quick – all we need is your name and a valid e-mail address. We appreciate your interest in bridges.